Table II.

Distribution of BR pre-mRNPs in the three BR gene segments after injection of control antibody or anti-SC35 antibody

Injection/experiment Proximal Middle Distal 
Uninjected    
 1 0.22 0.56 0.22 
 2 0.24 0.53 0.23 
 3 0.23 0.54 0.23 
 mean (c.v.) 0.23 (0.061) 0.54 (0.037) 0.23 (0.028) 
Control antibody    
 1 0.25 0.51 0.24 
 2 0.24 0.54 0.22 
 3 0.24 0.55 0.21 
 mean (c.v.) 0.24 (0.025) 0.53 (0.046) 0.22 (0.087) 
SC35 antibody    
 1 0.25 0.41 0.34 
 2 0.27 0.40 0.33 
 3 0.25 0.39 0.36 
 mean (c.v.) 0.26 (0.060) 0.40 (0.027) 0.34 (0.042) 
Injection/experiment Proximal Middle Distal 
Uninjected    
 1 0.22 0.56 0.22 
 2 0.24 0.53 0.23 
 3 0.23 0.54 0.23 
 mean (c.v.) 0.23 (0.061) 0.54 (0.037) 0.23 (0.028) 
Control antibody    
 1 0.25 0.51 0.24 
 2 0.24 0.54 0.22 
 3 0.24 0.55 0.21 
 mean (c.v.) 0.24 (0.025) 0.53 (0.046) 0.22 (0.087) 
SC35 antibody    
 1 0.25 0.41 0.34 
 2 0.27 0.40 0.33 
 3 0.25 0.39 0.36 
 mean (c.v.) 0.26 (0.060) 0.40 (0.027) 0.34 (0.042) 

c.v., coefficient of variation. Three independent experiments for each treatment are listed: uninjected cells, cells injected with control antibody, and cells injected with anti-SC35 antibody. For each experiment, the relative distribution of BR pre-mRNPs and one-way ANOVA analyses of log-transformed data are shown. Geometric mean and coefficient of variation are listed. P-values from one-way ANOVA are as follows: proximal, P = 0.095; middle, P = 0.00008; and distal, P = 0.0001.

or Create an Account

Close Modal
Close Modal